Niacin and contribution to normal energy‐yielding metabolism: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006
2015
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
Abstract Following an application from Specialised Nutrition Europe (formerly IDACE), submitted for authorisation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 via the Competent Authority of France, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to niacin and contribution to normal energy‐yielding metabolism. The Panel considers that niacin, the food constituent that is the subject of the health claim, is sufficiently characterised. Contribution to normal energy‐yielding metabolism is a beneficial physiological effect. The Panel has previously assessed a claim on niacin and contribution to normal energy‐yielding metabolism with a favourable outcome. The target population was the general population. The Panel considers that the role of niacin in contributing to normal energy‐yielding metabolism applies to all ages, including infants and young children (from birth to three years). The Panel concludes that a cause and effect relationship has been established between the dietary intake of niacin and contribution to normal energy‐yielding metabolism. The following wording reflects the scientific evidence: ‘Niacin contributes to normal energy‐yielding metabolism.’ The target population is infants and young children up to three years of age.
显示更多 [+] 显示较少 [-]